Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Annovis Bio, Inc. (ANVS)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Dec-31-22Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21
   10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q
Cash flows from operating activities:          
    Net loss  -9.5-9.7-3.1-7.6-5.9-5.2-5.9-2.8
    Adjustments to reconcile net loss to net cash used in operating activities:          
        Stock-based compensation expense  1.61.51.52.41.93.43.90.8
        Changes in operating assets and liabilities:          
            Prepaid expenses and other current assets  1.7-1.1-7.10.1-2.6-1.1-0.10.1
            Accounts payable  -3.00.22.10.90.00.20.40.2
            Accrued expenses  -0.4-2.53.10.3-0.1-0.40.00.1
                Net cash used in operating activities  -9.6-11.6-3.6-4.0-6.7-3.0-1.8-1.7
   
Cash flows from financing activities:          
    Proceeds from issuance of common stock, net of issuance costs  8.6       
    Proceeds from exercise of stock options  0.00.0   0.0  
        Net cash provided by financing activities  8.60.0   0.0 0.0
    Net (decrease) increase in cash and cash equivalents  -1.0-11.6-3.6-4.0-6.7-3.0-1.8-1.8

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy